{"product_id":"ignite-blend-m","title":"IGNITE Blend – The Metabolic Cutting Stack","description":"\u003cp data-modal-summary style=\"font-size:1.08rem;line-height:1.6;\"\u003e\u003cstrong\u003eIGNITE is the cutting stack for people who want to stay off the growth-hormone axis.\u003c\/strong\u003e NAD+, MOTS-c and 5-Amino-1MQ in one vial — three compounds that work the mitochondria and the NAD pathway directly, with no growth-hormone signaling at all. The metabolic counterpart to SHRED.\u003c\/p\u003e\n\u003chr\u003e\n\u003ch2\u003e🔥 IGNITE Blend — The Metabolic Cutting Stack\u003c\/h2\u003e\n\u003cp\u003e\u003cem\u003eFat loss from inside the cell, not from the pituitary.\u003c\/em\u003e\u003c\/p\u003e\n\u003ch3\u003eWhat it is, in plain English\u003c\/h3\u003e\n\u003cp\u003eMost cutting stacks lean on growth hormone — prompting the pituitary to release more of it, or borrowing a fragment of the molecule. IGNITE takes a different road entirely. It works the machinery inside the cell that decides whether fuel gets burned. NAD+ is the coenzyme every cell uses to turn food into energy, and levels fall steadily with age. 5-Amino-1MQ blocks an enzyme that quietly drains that NAD+ supply in fat tissue, so more of it stays available. MOTS-c is a peptide the mitochondria themselves produce, and it behaves like an exercise signal — switching on the pathways that burn fuel rather than store it. Three compounds, one target: the mitochondria.\u003c\/p\u003e\n\u003ch3\u003eHow it helps\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e🔥 A cutting stack with no growth-hormone signaling\u003c\/li\u003e\n\u003cli\u003e⚡ NAD+ and 5-Amino-1MQ work the same pathway from both ends\u003c\/li\u003e\n\u003cli\u003e🏃 MOTS-c targets mitochondrial fuel use directly\u003c\/li\u003e\n\u003cli\u003e🧪 Three compounds in one vial — one draw, one injection\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eWhy people reach for it\u003c\/h3\u003e\n\u003cp\u003eSome people want a body-composition stack but cannot, or would rather not, run a growth-hormone protocol — a personal history of cancer, blood-sugar concerns, or simply a preference to leave that axis alone. SHRED is closed to them. IGNITE is built for exactly that person. It also sits naturally alongside a GLP-1: the GLP-1 handles appetite, IGNITE handles what happens to the fuel.\u003c\/p\u003e\n\u003ctable\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003e \u003c\/th\u003e\n\u003cth\u003eSHRED Blend\u003c\/th\u003e\n\u003cth\u003eIGNITE Blend\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eApproach\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eGrowth-hormone axis\u003c\/td\u003e\n\u003ctd\u003eMitochondrial \/ NAD pathway\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eContains\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eAOD-9604, CJC-1295, Ipamorelin, MOTS-c\u003c\/td\u003e\n\u003ctd\u003eNAD+, MOTS-c, 5-Amino-1MQ\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eShared compound\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eMOTS-c\u003c\/td\u003e\n\u003ctd\u003eMOTS-c\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eGrowth-hormone signaling\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eYes\u003c\/td\u003e\n\u003ctd\u003eNone\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003ch3\u003eIs it a fit?\u003c\/h3\u003e\n\u003cp\u003eIGNITE suits someone focused on body composition who wants to stay off the growth-hormone axis, or who has been told to. Anyone comfortable with a GH-axis protocol and chasing lean mass as well as fat loss may find SHRED the stronger lever. Anyone whose main obstacle is appetite should look at the GLP-1 range first. Take the 60-second peptide quiz or message our team, and our providers can point the way.\u003c\/p\u003e\n\u003cdetails\u003e\n\u003csummary\u003e🔬 \u003cstrong\u003eFor the science-minded\u003c\/strong\u003e\u003c\/summary\u003e\n\u003cp\u003eNAD+ (nicotinamide adenine dinucleotide) is the central redox coenzyme of cellular energy metabolism and a substrate for the sirtuin and PARP enzyme families; tissue levels decline with age. 5-Amino-1MQ is a selective inhibitor of nicotinamide N-methyltransferase (NNMT); blocking NNMT spares nicotinamide for NAD+ synthesis via the salvage pathway and has been associated with reduced adipose mass in animal models. MOTS-c is a mitochondrial-derived peptide encoded in the 12S rRNA region of mitochondrial DNA, reported to activate AMPK and improve metabolic flexibility. None of the three acts on the growth-hormone \/ IGF-1 axis. Human trial data remain limited for 5-Amino-1MQ and MOTS-c.\u003c\/p\u003e\n\u003c\/details\u003e\n\u003cp\u003e\u003cstrong\u003eThis is not a growth-hormone-axis protocol. It carries none of the blood-sugar or cancer-history cautions that apply to SHRED, TITAN or the CJC \/ Ipamorelin stacks.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp style=\"font-size:.85rem;color:#6b7280;\"\u003e\u003cem\u003eEducational only — not medical advice. Peptides discussed here are research compounds; whether any is appropriate is a decision between a patient and their licensed provider.\u003c\/em\u003e\u003c\/p\u003e\n","brand":"Reflections","offers":[{"title":"100 mg NAD+ \/ 10 mg MOTS-c \/ 10 mg 5-Amino-1MQ","offer_id":51340521898151,"sku":null,"price":183.6,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0579\/5889\/1687\/files\/ignite-blend_94974c29-1173-4ac6-836d-61135859b555.jpg?v=1789434314","url":"https:\/\/reflectionshealth.co\/products\/ignite-blend-m","provider":"Reflections","version":"1.0","type":"link"}